These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16120203)

  • 1. Treatment options--development of consensus guidelines.
    Lecha M; Effendy I; Feuilhade de Chauvin M; Di Chiacchio N; Baran R;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():25-33. PubMed ID: 16120203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
    Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
    Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimycotic therapy of Tinea unguium and other onychomycoses].
    Stock I
    Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Literature review. Onychomycosis.
    Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():1-7. PubMed ID: 16120198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
    Avner S; Nir N; Henri T
    J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of antifungal therapy, part II: treatment rationale, including specific patient populations.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(3):168-75. PubMed ID: 18569273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
    Baran R
    Br J Dermatol; 2001 Oct; 145 Suppl 60():15-9. PubMed ID: 11777260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate.
    Finnen MJ; Hennessy A; McLean S; Bisset Y; Mitchell R; Megson IL; Weller R
    Br J Dermatol; 2007 Sep; 157(3):494-500. PubMed ID: 17627796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and clinical classification of onychomycosis.
    Effendy I; Lecha M; Feuilhade de Chauvin M; Di Chiacchio N; Baran R;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():8-12. PubMed ID: 16120199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis.
    Sumikawa M; Egawa T; Honda I; Yamamoto Y; Sumikawa Y; Kubota M
    J Dermatol; 2007 Jul; 34(7):456-64. PubMed ID: 17584323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of onychomycosis therapy may involve a combination of approaches.
    Hay RJ
    Br J Dermatol; 2001 Oct; 145 Suppl 60():3-8. PubMed ID: 11777262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of nail mycoses].
    Rakosi T
    Ther Umsch; 1989 Feb; 46(2):107-10. PubMed ID: 2522685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toenail onychomycosis: current and future treatment options.
    Finch JJ; Warshaw EM
    Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common tinea infections in children.
    Andrews MD; Burns M
    Am Fam Physician; 2008 May; 77(10):1415-20. PubMed ID: 18533375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Today's treatments options for onychomycosis.
    Iorizzo M; Piraccini BM; Tosti A
    J Dtsch Dermatol Ges; 2010 Nov; 8(11):875-9. PubMed ID: 20738460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.